Literature DB >> 32016383

Serum Anti-Müllerian Hormone in the Prediction of Response to hCG Stimulation in Children With DSD.

Angela K Lucas-Herald1,2, Andreas Kyriakou1, Malika Alimussina1, Guilherme Guaragna-Filho3, Louise A Diver4, Ruth McGowan1,4, Karen Smith5, Jane D McNeilly6, S Faisal Ahmed1.   

Abstract

INTRODUCTION: The relationship between serum anti-Müllerian hormone (AMH) and the testosterone response to human chorionic gonadotropin (hCG) stimulation test is unclear.
METHODS: Children who had hCG stimulation tests in one tertiary centre from 2001 to 2018 were included (n = 138). Serum testosterone was measured before (day 1 [D1]) and after 3 days (D4) of hCG stimulation. Sixty-one of these children also had prolonged hCG stimulation for 2 more weeks and serum testosterone measured after 21 days (D22). All children had a serum AMH measured on D1.
RESULTS: Of the 138 children, D4 testosterone was normal in 104 (75%). AMH was low in 24/138 (17%) children, and 16 (67%) of these had a low D4 testosterone. Median AMH in those who had a normal vs low D4 testosterone was 850 pmol/L (24, 2280) and 54 pmol/L (0.4, 1664), respectively (P < 0.0001). An AMH > 5th centile was associated with a low D4 testosterone in 18/118 (13%; P < 0.0001). Of the 61 children who had prolonged hCG stimulation, D22 testosterone was normal in 39 (64%). AMH was low in 10/61(16%) children and 9 (90%) of these had a low D22 testosterone. Median AMH in children who responded and did not respond by D22 was 639 pmol/L (107, 2280) and 261 pmol/L (15, 1034) (P < 0.0001).
CONCLUSION: A normal AMH may provide valuable information on overall testicular function. However, a low AMH does not necessarily predict a suboptimal testosterone response to hCG stimulation. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  AMH; DSD; androgen; testes

Year:  2020        PMID: 32016383      PMCID: PMC7096311          DOI: 10.1210/clinem/dgaa052

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  32 in total

1.  Androgen-responsive non-coding small RNAs extend the potential of HCG stimulation to act as a bioassay of androgen sufficiency.

Authors:  M E Rodie; M A V Mudaliar; P Herzyk; M McMillan; M Boroujerdi; S Chudleigh; E S Tobias; S F Ahmed
Journal:  Eur J Endocrinol       Date:  2017-07-21       Impact factor: 6.664

2.  Pitfalls in hormonal diagnosis of 17-beta hydroxysteroid dehydrogenase III deficiency.

Authors:  Ahmed Khattab; Tony Yuen; Mabel Yau; Sorahia Domenice; Elaine Maria Frade Costa; Kazmi Diya; Dwaipayan Muhuri; Christian Enrique Pina; Mirian Yumie Nishi; Amy C Yang; Berenice Biharinho de Mendonça; Maria I New
Journal:  J Pediatr Endocrinol Metab       Date:  2015-05       Impact factor: 1.634

3.  Biochemical selection of prepubertal patients with androgen insensitivity syndrome by sex hormone-binding globulin response to the human chorionic gonadotropin test.

Authors:  S Bertelloni; G Federico; G I Baroncelli; L Cavallo; G Corsello; A Liotta; F Rigon; G Saggese
Journal:  Pediatr Res       Date:  1997-02       Impact factor: 3.756

4.  Desensitization of steroidogenesis in cultured Leydig tumor cells: role of cholesterol.

Authors:  D A Freeman; M Ascoli
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

5.  Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.

Authors:  M M Lee; P K Donahoe; T Hasegawa; B Silverman; G B Crist; S Best; Y Hasegawa; R A Noto; D Schoenfeld; D T MacLaughlin
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

6.  Anti-müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development.

Authors:  R Rey; I Lordereau-Richard; J C Carel; P Barbet; R L Cate; M Roger; J L Chaussain; N Josso
Journal:  J Clin Endocrinol Metab       Date:  1993-11       Impact factor: 5.958

7.  5α-Reductase-2 Deficiency: Clinical Findings, Endocrine Pitfalls, and Genetic Features in a Large Italian Cohort.

Authors:  Silvano Bertelloni; Fulvia Baldinotti; Gianni Russo; Paolo Ghirri; Eleonora Dati; Angela Michelucci; Francesca Moscuzza; Silvia Meroni; Ilaria Colombo; Maria R Sessa; Giampiero I Baroncelli
Journal:  Sex Dev       Date:  2016-04-13       Impact factor: 1.824

8.  Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015).

Authors:  S Faisal Ahmed; John C Achermann; Wiebke Arlt; Adam Balen; Gerry Conway; Zoe Edwards; Sue Elford; Ieuan A Hughes; Louise Izatt; Nils Krone; Harriet Miles; Stuart O'Toole; Les Perry; Caroline Sanders; Margaret Simmonds; Andrew Watt; Debbie Willis
Journal:  Clin Endocrinol (Oxf)       Date:  2015-08-13       Impact factor: 3.478

Review 9.  Anti-müllerian hormone and its clinical use in pediatrics with special emphasis on disorders of sex development.

Authors:  Marie Lindhardt Johansen; Casper P Hagen; Trine Holm Johannsen; Katharina M Main; Jean-Yves Picard; Anne Jørgensen; Ewa Rajpert-De Meyts; Anders Juul
Journal:  Int J Endocrinol       Date:  2013-12-03       Impact factor: 3.257

Review 10.  The Role of International Databases in Understanding the Aetiology and Consequences of Differences/Disorders of Sex Development.

Authors:  Salma Rashid Ali; Angela Lucas-Herald; Jillian Bryce; Syed Faisal Ahmed
Journal:  Int J Mol Sci       Date:  2019-09-07       Impact factor: 5.923

View more
  4 in total

1.  Serum Anti-Müllerian Hormone in the Prediction of Response to hCG Stimulation in Children With DSD.

Authors:  Angela K Lucas-Herald; Andreas Kyriakou; Malika Alimussina; Guilherme Guaragna-Filho; Louise A Diver; Ruth McGowan; Karen Smith; Jane D McNeilly; S Faisal Ahmed
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

Review 2.  Congenital Micropenis: Etiology And Management.

Authors:  Marianna Rita Stancampiano; Kentaro Suzuki; Stuart O'Toole; Gianni Russo; Gen Yamada; Syed Faisal Ahmed
Journal:  J Endocr Soc       Date:  2021-11-15

3.  Clinical Utility of Anti-Mullerian Hormone in Pediatrics.

Authors:  Roopa Kanakatti Shankar; Tazim Dowlut-McElroy; Andrew Dauber; Veronica Gomez-Lobo
Journal:  J Clin Endocrinol Metab       Date:  2022-01-18       Impact factor: 5.958

Review 4.  Testicular Sertoli Cell Hormones in Differences in Sex Development.

Authors:  Angela K Lucas-Herald; Rod T Mitchell
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.